AMF Tjanstepension AB Has $67.06 Million Stake in Danaher Corporation $DHR

AMF Tjanstepension AB decreased its position in Danaher Corporation (NYSE:DHR) by 2.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 353,691 shares of the conglomerate’s stock after selling 9,976 shares during the quarter. AMF Tjanstepension AB’s holdings in Danaher were worth $67,060,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. JPL Wealth Management LLC purchased a new position in shares of Danaher in the 3rd quarter worth approximately $25,000. Elevated Capital Advisors LLC bought a new position in Danaher during the fourth quarter valued at about $26,000. WFA of San Diego LLC purchased a new position in Danaher in the second quarter valued at about $26,000. Hilton Head Capital Partners LLC bought a new position in Danaher during the fourth quarter valued at $27,000. Finally, Clal Insurance Enterprises Holdings Ltd increased its position in Danaher by 71.6% in the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock worth $29,000 after buying an additional 53 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Up 0.0%

DHR opened at $199.11 on Monday. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33. The business’s 50-day moving average price is $180.59 and its 200-day moving average price is $199.27. The company has a market cap of $140.92 billion, a P/E ratio of 38.51, a P/E/G ratio of 2.54 and a beta of 0.79.

Danaher (NYSE:DHR) last issued its earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, beating the consensus estimate of $1.94 by $0.12. The company had revenue of $5.95 billion during the quarter, compared to analysts’ expectations of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.Danaher’s quarterly revenue was up 3.7% compared to the same quarter last year. During the same period in the prior year, the business posted $1.88 EPS. On average, equities analysts expect that Danaher Corporation will post 8.44 EPS for the current year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Friday, June 26th. Danaher’s dividend payout ratio is currently 30.95%.

Analyst Upgrades and Downgrades

Several research firms have commented on DHR. Morgan Stanley dropped their price objective on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a report on Wednesday, April 22nd. Royal Bank Of Canada started coverage on Danaher in a research report on Thursday, May 14th. They set an “outperform” rating and a $200.00 target price on the stock. Evercore restated an “outperform” rating and issued a $230.00 price objective on shares of Danaher in a research report on Monday, July 6th. Rothschild & Co Redburn set a $205.00 price objective on shares of Danaher in a research note on Friday, April 17th. Finally, Robert W. Baird dropped their price objective on Danaher from $251.00 to $249.00 and set an “outperform” rating for the company in a research note on Friday, April 17th. One research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Danaher currently has an average rating of “Moderate Buy” and an average price target of $231.64.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.